| Literature DB >> 25475078 |
Immacolata Porreca, Fulvio D'Angelo, Daniela Gentilcore, Emanuele Carchia, Angela Amoresano, Andrea Affuso, Michele Ceccarelli, Pasquale De Luca, Libera Esposito, Francesco M Guadagno, Massimo Mallardo, Antonio Nardone, Sergio Maccarone, Francesca Pane, Marzia Scarfò, Paolo Sordino, Mario De Felice, Concetta Ambrosino1.
Abstract
BACKGROUND: Comparison of toxicogenomic data facilitates the identification of deregulated gene patterns and maximizes health risk prediction in human.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25475078 PMCID: PMC4301944 DOI: 10.1186/1471-2164-15-1067
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Molecular characterization of acutely exposed mice liver. (A) Heatmap showing the expression profiles in Ctrl, U and D waters treated mice livers. The expression value of each gene is mapped to a colour-intensity value, as indicated by the colour bar. (B) Venn Diagram showing the probe sets overlap in U (orange) and D (blue) groups compared to the control. (C) Canonical pathways, identified by IPA analysis, deregulated in liver of U and D waters exposed mice. The left y-axis value is the negative lg10(Benjamini-Hochberg corrected p-value). The orange squares referred to the right y-axis represent the ratio values indicating the percentage of genes in the pathway that are also deregulated. (D) Toxfunctions deregulated in U and D exposed animal livers. (E) qRT-PCR validation of some DEGs. Data are reported as the negative inverse of fold change value calculated as ratio between average expression in U/D and in Ctrl exposed animals (8 animals/group).
Figure 2Biochemical analyses in acutely exposed mice. (A) Serum Urea, (B) AP, (C) AST and (D) ALT levels were measured in Ctrl (black), U (orange) and D waters (blue) treated mice (20 animals/group). Each sign is a single mouse. Mean and standard deviation is reported. **p-value ≤0,01.
Figure 3Toxicogenomics analyses in acute exposed zebrafish. (A) Venn Diagram showing the probe set overlap in U (orange) and D (blue) compared to the control group. (B) qRT-PCR validation of selected genes (LOC794625 and Cpt2) deregulated in exposed zebrafish livers. Data are reported as the negative inverse of fold change value calculated as ratio between average expression in U/D and in Ctrl exposed animals (8 animals/group). (C) Canonical pathways identified by IPA analysis on common DEGs in zebrafish livers. See Figure 5 caption for graphic description.
Figure 5Schematic representation of exposure windows in mice. P generation mice were treated for 3 (acute exposure) and for 12 months (chronic exposure), starting from 21 PND. F1 generation mice, obtained by crossing 4 months old P mice, were treated for 12 months starting from embryonic day 0. In black horizontal line the experiment duration; in yellow and orange exposure duration for P and F1, respectively; the red crosses indicate the end of the treatment.
Figure 4Validation of hormonal alteration in acutely exposed mice and zebrafish. (A) Vtg mRNA level measured by qRT-PCR in liver of zebrafish females (20 animals/group). Each sign is a single animal. (B) Serum estradiol levels measured by ELISA assay in acute exposed mouse females (15 animals/group). Each sign is a single animal. Mean and standard deviation is reported. *p-value ≤0,05, **p-value ≤0,01.
Figure 6Transcriptomics analyses in livers of 12 months P exposed mice. (A) Venn Diagram showing probe set overlap between U (orange) and D (blue) compared to the control group after 12 months of treatment started at PND 21. (B) Canonical pathways deregulated in liver of exposed P mice. See Figure 5 caption for graphic description.
Figure 7Transcriptomics analyses in livers of F1 mice exposed in utero and for 12 months. (A) Venn Diagram showing the probe set overlap between U (orange) and D (blue) compared to the control group after 12 months of treatment started at GD 0 in F1. (B) Biofunctions deregulated in liver of F1 exposed animals. See Figure 5 caption for graphic description.
Genes deregulated in livers of both 3 and 12 months mice exposed to U and D waters
| Transcripts Cluster Id | Gene name | Gene description | Fold change | |||
|---|---|---|---|---|---|---|
| 3 months | 12 months | |||||
| U vs Ctrl | D vs Ctrl | U vs Ctrl | D vs Ctrl | |||
| 10603833 | Usmg5 | Upregulated during skeletal muscle growth 5 | -4.53 | -4.28 | -2.83 | -2.95 |
| 10374476 | Rps17 | Ribosomal protein S17 | -2.96 | -3.19 | -1.85 | -1.89 |
| 10357242 | Dbi | Diazepam binding inhibitor | -2.87 | -2.71 | -1.84 | -2.23 |
| 10387816 | Rnasek | Ribonuclease, RNase K | -2.17 | -2.33 | -1.61 | -1.78 |
| 10344817 | Cspp1 | Centrosome and spindle pole associated protein 1 | -1.75 | -1.62 | -1.80 | -2.38 |
| 10483809 | Nfe2l2 | Nuclear factor, erythroid derived 2, like 2 | -1.66 | -1.78 | -1.71 | -1.81 |
| 10500798 | -1.57 | -1.78 | -2.75 | -2.78 | ||
| 10598089 | mt-Te | tRNA glutamic acid, mitochondrial | 2.12 | 2.47 | 4.20 | 5.01 |
| 10598087 | ND6 | NADH dehydrogenase subunit 6 | 2.82 | 3.37 | 1.86 | 3.73 |
| 10598073 | mt-Tq | tRNA glutamine, mitochondrial | 4.07 | 5.85 | 5.67 | 7.28 |
| 10528191 | Speer4d|Speer4c|Speer4e| | Spermatogenesis associated glutamate (E)-rich protein 4d/4c/4e | 4.13 | 4.67 | 1.65 | 1.80 |
| 10598083 | mt-Ts1 | tRNA serine 1, mitochondrial | 5.32 | 6.71 | 3.00 | 4.83 |
| 10598091 | mt-Tp | tRNA proline, mitochondrial | 5.62 | 7.62 | 3.11 | 3.85 |
| 10598075 | mt-Ta | tRNA alanine, mitochondrial | 5.93 | 7.82 | 16.92 | 26.75 |
| 10598023 | mt-Tv | tRNA valine, mitochondrial | 6.17 | 6.69 | 4.21 | 5.75 |
| 10519811 | Speer8-ps1|Speer7-ps1 | Spermatogenesis associated glutamate (E)-rich protein 7/8, pseudogene 1 | 6.34 | 6.92 | 3.13 | 3.88 |
| 10598057 | mt-Tr | tRNA arginine, mitochondrial | 6.40 | 7.63 | 10.12 | 28.13 |
| 10436773 | Gm7735|Gm9789 | 6.48 | 6.90 | 3.75 | 3.25 | |
| 10412517 | Gm3002|Gm10021|Gm3512 | 7.66 | 10.80 | 3.88 | 4.55 | |
| 10582888 | 7.70 | 9.65 | 2.83 | 5.64 | ||
| 10598081 | mt-Ty | tRNA tyrosine, mitochondrial | 10.46 | 13.91 | 6.51 | 10.49 |
| 10598079 | mt-Tc | tRNA cysteine, mitochondrial | 10.88 | 15.64 | 4.72 | 7.30 |
| 10598018 | mt-Tf | tRNA phenylalanine, mitochondrial | 11.56 | 14.23 | 14.71 | 27.37 |
| 10598062 | mt-Th | tRNA histidine, mitochondrial | 13.20 | 15.78 | 27.68 | 46.30 |
| 10598077 | mt-Tn | tRNA asparagine, mitochondrial | 21.72 | 32.04 | 6.55 | 9.85 |
| 10598041 | mt-Tk | tRNA lysine, mitochondrial | 24.14 | 28.86 | 39.43 | 66.79 |
| 10598071 | mt-Tt | tRNA threonine, mitochondrial | 27.51 | 35.77 | 7.81 | 15.37 |
| 10598064 | mt-Tl2 | tRNA leucine 2, mitochondrial | 58.00 | 70.56 | 44.83 | 70.91 |
|
|
| Small nucleolar RNA, C/D box 87 | -3.20 | -3.39 | 2.83 | 2.77 |
|
|
| Ribosomal protein S25 | predicted gene 4963 | -1.70 | -1.81 | 1.75 | 1.80 |
|
|
| RIKEN cDNA 5730408 K05 gene | -2.26 | -2.30 | 4.41 | 4.10 |
In bold, genes inversely deregulated in the two data sets. mt- stays for mitochondrial.
The arithmetic fold change is reported.
Genes deregulated in chronic exposure liver tissue of U and D treated mice in both P and F1
| Transcripts Cluster Id | Gene name | Gene description | Fold change | |||
|---|---|---|---|---|---|---|
| P | F1 | |||||
| U vs Ctrl | D vs Ctrl | U vs Ctrl | D vs Ctrl | |||
| 10572813 | Usmg5 | Upregulated during skeletal muscle growth 5 | -2.89 | -3.19 | -1.54 | -1.66 |
| 10598062 | NC_005089* | 27.68 | 46.30 | 5.28 | 3.63 | |
| 10598064 | NC_005089* | 44.83 | 70.91 | 3.40 | 2.29 | |
| 10598087 | ND6 | NADH dehydrogenase subunit 6 | 1.86 | 3.73 | 3.76 | 4.43 |
|
|
| microRNA 703 | 1.61 | 1.64 | -1.74 | -1.73 |
|
| 3.51 | 3.20 | -1.76 | -1.94 | ||
|
| 3.59 | 3.32 | -1.86 | -2.16 | ||
|
|
| RNA component of mitochondrial RNAase P | 2.49 | 2.66 | -2.10 | -2.30 |
|
|
| 4.51 | 4.26 | -2.36 | -2.49 | |
*Mitochondrial genome.
In bold, genes inversely deregulated in the two data sets parents (P) and offspring (F1).
The arithmetic fold change is reported.
Genes analysed by qRT-PCR
| Gene name | Gene description | Forward primer 5’-3’ | Reverse primer 5’-3’ |
|---|---|---|---|
| Cdkn1a | Cyclin-dependent kinase inhibitor 1A (P21) | atccagacattcagagccacag | acgaagtcaaagttccaccgt |
| Hp | Haptoglobin | cttccagagagaggcaagaga | gcccaactccacagcaaaaag |
| Lbp | Lipopolysaccharide binding protein | gcatccagacaaggcacaag | cgaggtcgtggagctgaata |
| Pnrc1 | Proline-rich nuclear receptor coactivator 1 | ccacagacagcccccactc | tgtataccatgcacaagctggc |
| Ppp1r3c | Protein phosphatase 1, regulatory (inhibitor) subunit 3C | caatgagctgcaccagaatga | gtggtgaatgagccaagcaa |
| Sox9 | SRY-box containing gene 9 | tctggaggctgctgaacgag | gcttgtccgttcttcaccga |
| Vtn | Vitronectin | agtgcaagccccaagtaacg | ccgtccgtccgaggatttag |
| Nfe2l2 | Nuclear factor, erythroid derived 2, like 2 | gcatgatggacttggagttgc | gctcatagtccttctgtcgct |
| Mavs | Mitochondrial antiviral signaling protein | tatccgagacaaccacagcaa | gtcgatcaagatgactgggtg |
| C1qa | Complement component 1, q subcomponent, alpha polypeptide | tgtcccaccatcagcaaagg | gtctccatggtgtccctgc |
| C1qb | Complement component 1, q subcomponent, beta polypeptide | gacccagacttccgctttct | ctcaccccactgtgtcttca |
| C1qc | Complement component 1, q subcomponent, C chain | accctcaggatggtcgttgg | tgagtggtagggccagaaga |
| Tub-α | Tubulin-α | caacaccttcttcagtgagacagg | tacatgatctccttgccaatggt |
| LOC794625 | Up-regulated during skeletal muscle growth protein 5 | gggcaccagtttgcttgattg | cctcctgccagtgattgtgt |
| Cpt2 | Carnitine palmitoyltransferase II | aaccgctggtacgacaa | ggacgcaggctgagaac |
| Rpl13a | Ribosomal protein L13A | tctggaggactgtaagaggtatgc | agacgcacaatcttgagagcag |